Trial Profile
Effect of tiotropium on exercise tolerance and static and dynamic lung volumes in COPD [chronic obstructive pulmonary disease] patients (a randomized, double-blind, placebo-controlled, parallel group study)
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 04 Dec 2023
Price :
$35
*
At a glance
- Drugs Tiotropium bromide (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Registrational; Therapeutic Use
- Sponsors Boehringer Ingelheim
- 29 Mar 2007 New trial record.